4//SEC Filing
McIntyre David 4
Accession 0000950170-25-054712
CIK 0001750149other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:06 PM ET
Size
5.3 KB
Accession
0000950170-25-054712
Insider Transaction Report
Form 4
McIntyre David
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-14+1,775,539→ 1,775,539 totalExercise: $2.00Exp: 2035-04-14→ Common Stock (1,775,539 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on April 14, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued employment on each such vesting date.
Documents
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeother
Related Parties
1- filerCIK 0001404254
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 4:06 PM ET
- Size
- 5.3 KB